22. Oct 2015
Dellann Elliott Mydland to Speak at 2nd Annual Turning Point Conference, San Antonio, Texas
Dellann Elliott Mydland to Speak at 2nd Annual Turning Point Conference, San Antonio, Texas We are pleased to inform you that Dellann Elliott Mydland will be a featured speaker at a national brain tumor conference entitled “At a Turning Point: Novel Therapeutic Developments in Glioblastoma Multiforme (GBM) Research.” The conference precedes the Society for Neuro-Oncology’s Annual Meeting. Dellann will be further advancing The EndBrainCancer Initiative through her address and networking. EBC is a sponsor of the event. MORE INFORMATION AND REGISTRATION
22. Oct 2015
EndBrainCancer / Chris Elliott Fund Honored as Social Impact Innovator—Fast Pitch Awards Ceremony on October 27th
EndBrainCancer / Chris Elliott Fund Honored as Social Impact Innovator—Fast Pitch Awards Ceremony on October 27th SVP Fast Pitch is the region’s premier competition igniting social innovation. This year, over 100 organizations applied and we are proud to report that EndBrainCancer / Chris Elliott Fund made it as a quarterfinalist! SVP Fast Pitch is produced by Social Venture Partners (SVP), the world’s largest network of engaged philanthropists and the event is almost entirely run by over 100 dedicated volunteers. Volunteer coaches have been helping Dellann Mydland and The EndBrainCancer Initiative improve our pitch. JOIN US FOR THE SVP FAST PITCH AWARDS EVENT On October 27, the best innovators pitch live at McCaw Hall in Seattle Center before an audience of nearly 1,000 philanthropists, investors, and community leaders. A general admission ticket costs $125. The ticket price includes great networking, entertainment (e.g., the inspiration pitches), food and wine, and, most important, funding the prizes for the non-profit winners. A large portion of your ticket cost is tax deductible. You may register online.
22. Oct 2015
ChrisElliottFund Officially Re-launched as The EndBrainCancer Initiative
Chris Elliott Fund Officially Re-launched as The EndBrainCancer Initiative The Chris Elliott Fund has officially re-launched in 2015 as the EndBrainCancer Initiative. Historically, our 501 (c)3 non-profit corporation has been associated with Christopher Stewart Elliott, co-founder, who himself bravely fought brain cancer and started the Fund with his wife, Dellann, before passing in 2002. The goal of the organization is and has always been about providing IMMEDIATE ACCESS to advanced treatments, studies and clinical trials at the time of diagnosis vs. waiting to have this conversation after all Standard of Care treatments have failed. It has been about being Proactive rather than Reactive to brain cancer. The primary reason behind our name change and new initiative is because industry, pharmaceutical companies, major donors and other partners have not fully understood that our direct one-on-one version of “Patient Support” has always been about fueling research through a Patient Focus and about getting these patients into advanced treatments quickly in order to create a greater quality of life, longer survivorship and perhaps, survivorship. As an organization, we had never properly defined our version of “Patient Support” and how our work leads to translational medicine and additional treatments quicker than the traditional […]